On the other hand, an increasing amount of evidence points to a pro-oncogenic role played by the RUNX1 gene in breast cancer, intriguingly associated with the ER negative and triple negative (TN, i.e., ER-, PR-, HER2-) subtypes [59]. This evidence concerns the gene ESR1 and breast carcinoma.